Log in

OTCMKTS:DSRLFDiaSorin Stock Price, Forecast & News

$190.00
0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$190.00
Now: $190.00
$190.00
50-Day Range
$125.00
MA: $164.43
$217.00
52-Week Range
$114.50
Now: $190.00
$217.00
Volume88 shs
Average Volume123 shs
Market Capitalization$10.63 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.97
DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. The company's immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips to automate microplate based assays; and ETI Max 3000, an automated microtiter plate analyzer. It also offers molecular diagnostic products LIAISON MDX a thermocycler; and LIAISON IAM, an instrument for amplification of nucleic acids, as well as kits, PCR master mixes, primer pairs, and molecular controls for monitoring oncology and infectious diseases. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, North Americam Central America, South America, and the Asia Pacific. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars


Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:DSRLF
CUSIPN/A
CIKN/A
Phone390-161-4871

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$790.32 million
Cash Flow$4.41 per share
Book Value$14.88 per share

Profitability

Miscellaneous

Employees1,928
Market Cap$10.63 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive DSRLF News and Ratings via Email

Sign-up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter.

DiaSorin (OTCMKTS:DSRLF) Frequently Asked Questions

How has DiaSorin's stock been impacted by COVID-19 (Coronavirus)?

DiaSorin's stock was trading at $122.5186 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DSRLF stock has increased by 55.1% and is now trading at $190.00. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of DiaSorin?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DiaSorin in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for DiaSorin.

Has DiaSorin been receiving favorable news coverage?

Media coverage about DSRLF stock has trended very negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. DiaSorin earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutDiaSorin.

Who are some of DiaSorin's key competitors?

Who are DiaSorin's key executives?

DiaSorin's management team includes the following people:
  • Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 53)
  • Dr. Chen Menachem Even, Chief Commercial Officer & Exec. Director (Age 56)
  • Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 48)
  • Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. Communication
  • Mr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department

What is DiaSorin's stock symbol?

DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF."

How do I buy shares of DiaSorin?

Shares of DSRLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is DiaSorin's stock price today?

One share of DSRLF stock can currently be purchased for approximately $190.00.

How big of a company is DiaSorin?

DiaSorin has a market capitalization of $10.63 billion and generates $790.32 million in revenue each year. DiaSorin employs 1,928 workers across the globe.

What is DiaSorin's official website?

The official website for DiaSorin is www.diasoringroup.com.

How can I contact DiaSorin?

DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The company can be reached via phone at 390-161-4871 or via email at [email protected]

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.